Krystal Biotech, Inc. Common Stock KRYS
$337.02
-1.84%
at last close
Analyst Consensus
- Consensus Rating
- Buy (10 Buy · 1 Hold · 0 Sell)
- Average Price Target
- $355.10
- Implied Upside
- +5.4%
- Price Target Range
- $284.00 – $403.00
- Analysts (12 mo)
- 11
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-08-14 | RBC CapitalLisa Walter |
Initiates coverage on | Outperform | $400 |
| 2026-08-04 | CitigroupYigal Nochomovitz |
Maintains | Buy | $378 → $386 |
| 2026-07-14 | B of A SecuritiesAlec Stranahan |
Maintains | Buy | $364 → $396 |
| 2026-06-18 | TD CowenRitu Baral |
Maintains | Buy | $306 → $403 |
| 2026-06-16 | HC Wainwright & Co.Joseph Pantginis |
Maintains | Buy | $310 → $361 |
| 2026-06-01 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $310 |
| 2026-05-22 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $310 |
| 2026-05-18 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $310 |
| 2026-05-05 | CitigroupYigal Nochomovitz |
Maintains | Buy | $371 → $378 |
| 2026-05-05 | Evercore ISI GroupGavin Clark-Gartner |
Maintains | Outperform | $295 → $300 |
| 2026-05-04 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $310 |
| 2026-03-27 | Wolfe ResearchKalpit Patel |
Initiates coverage on | Peer perform | — |
| 2026-02-25 | GuggenheimDebjit Chattopadhyay |
Maintains | Buy | $224 → $284 |
| 2026-02-18 | CitigroupYigal Nochomovitz |
Maintains | Buy | $336 → $371 |
| 2026-02-18 | Chardan CapitalGeulah Livshits |
Maintains | Buy | $220 → $323 |
| 2026-02-17 | JefferiesRoger Song |
Maintains | Buy | $310 → $371 |
| 2026-02-02 | Goldman SachsAndrea Tan |
Maintains | Buy | $206 → $327 |
| 2026-01-22 | B of A SecuritiesAlec Stranahan |
Maintains | Buy | $288 → $318 |
| 2026-01-12 | CitigroupYigal Nochomovitz |
Maintains | Buy | $320 → $336 |
| 2026-01-09 | TD CowenRitu Baral |
Maintains | Buy | $202 → $306 |
| 2026-01-09 | CitigroupYigal Nochomovitz |
Maintains | Buy | $309 → $320 |
| 2026-01-09 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $240 → $310 |
| 2026-01-06 | CitigroupYigal Nochomovitz |
Upgrades | Neutral → Buy | $198 → $309 |
| 2025-11-04 | CitigroupYigal Nochomovitz |
Maintains | Neutral | $166 → $198 |
| 2025-11-04 | Chardan CapitalGeulah Livshits |
Maintains | Buy | $216 → $220 |
| 2025-10-17 | B of A SecuritiesAlec Stranahan |
Maintains | Buy | $182 → $255 |
| 2025-09-15 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $240 |
| 2025-08-22 | Chardan CapitalGeulah Livshits |
Maintains | Buy | $219 → $216 |
| 2025-08-22 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $240 |
| 2025-08-05 | CitigroupYigal Nochomovitz |
Maintains | Neutral | $176 → $166 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $337.02
- Market Cap
- $10.16 billion
- 52-Week Range
- $130.50 – $382.54
- Average Volume
- 496K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.